Friday, 29 April 2022
Thursday, 28 April 2022
Wednesday, 27 April 2022
Tuesday, 26 April 2022
Monday, 25 April 2022
Friday, 22 April 2022
Investor Ideas #Potcasts 631, #Cannabis News and #Stocks on the Move- #420 Roundup
Investor Ideas #Potcasts
631, #Cannabis News and #Stocks on the Move- #420 Roundup
Delta, Kelowna, BC, April 21st, 2022 (Investorideas.com
Newswire), investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Watch today’s
potcast on YouTube
https://www.youtube.com/watch?v=ucALpcZWc7E
Read this in full
at https://www.investorideas.com/news/2022/cannabis-potcasts/04221420-Roundup.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Happy Belated 4/20!
In today’s podcast we will be looking at a few different reports and news
articles focussing on where the cannabis industry is today, where it’s going
and how this year’s 4/20 highlighted some of these findings.
Looking
at a new report from New Frontier
Data titled “Cannabis Consumers in America: Dynamics Shaping
Normalization in 2022” we see that “Across both legal and illicit markets,
consumption patterns are normalizing to where demographic variables such as age
and gender are more influential than market legality in predicting behaviors
that are increasingly routine. The report’s findings concluded that cannabis
consumers are becoming more intentional with the plant’s use, and the primary
reasons for consumption now span relaxation, pain management, improving sleep
outcomes, treating medical conditions and improving overall wellness.
Since
2018, New Frontier Data has surveyed more than 20,000 consumers to benchmark
and analyze cannabis consumer behavior for endemic and non-endemic
organizations.
“Cannabis is no longer a one-size-fits-all
industry,” noted Gary Allen, CEO, New Frontier Data. “It’s now a commercial
imperative for brands, retailers and operators to do the homework required to
understand their ideal customer, why they consume and what products they
prefer.”
In the
report it was stated that “With combined U.S. legal and illicit sales estimated at $97 billion in 2021, can-
nabis consumer demand in America now
exceeds what the nation annually spends
on spirits, and roughly matches what it
spends on beer. Continued strong growth in legal demand, which is expected to serve
most U.S. demand by 2030, is driving
surging interest in cannabis among CPG
companies, investors, and entrepreneurs
alike.”
“Furthermore,
as science continues to affirm the comparative health effects of alcohol and tobacco relative to
cannabis, and social acceptance of cannabis increases, more consumers will expectedly substitute
cannabis for alcohol in the coming years, and in the process, increase the acceptability and use
of cannabis in American social society.”
Some of
the other key takeaways from the report were:
●
Nearly half (46%) of all survey respondents
report using cannabis daily as product selection expands with more convenient,
discreet and precise consumption methods.
●
Flower accounts for half of all legal sales
nationally, but the majority of consumers are now using non-flower products, as
the quality and selection of products expands.
●
The collective curiosity of consumers to
try new forms of cannabis is fueling product innovation and highlighting the
importance of targeted brand and loyalty strategies.
●
Positive outcomes from medical cannabis use
are driving increased acceptance as half of medical cannabis patients report
their conditions improved significantly and 93% report at least some
improvement.
The
report also included that “Cannabis consumers were more than twice as likely to self-identify as LGBTQ
compared to the general population. The
overindexing of cannabis use within the LGBTQ community presents an
opportunity for further research into
why cannabis use is so much higher among that group, and for brands to
understand the importance of the LGBTQ
community in their consumer bases. While
Pride Month has become a major
celebration on the U.S. retail calendar,
given the large representation of the
LGBTQ community in the cannabis consum- er base, cannabis brands and
retailers would be advised to consider
opportunities to serve the community not
just during Pride Month, but throughout
the year.”
The
report also conlcluded that “With more
than half of the country now living in states
where cannabis is legal in some form, and with an additional 18 states poised to legalize
either medical or adult-use programs over the next decade, nearly all Americans (96%) could be living in
legal cannabis markets by 2030.”
Another
sign pointing to renewed interest in the cannabis industry was with Roundhill Investments who announced its debut of its cannabis-themed
exchange-traded fund yesterday.
The Roundhill Cannabis ETF (WEED)
will invest in exchange-listed equities and total return swaps that have
exposure to the cannabis and hemp markets, according to a filing
with the U.S. Securities and Exchange Commission. It will be listed on the Cboe
BZX Exchange.
“While publicly-listed cannabis
companies have recently underperformed, we believe that the cannabis market may
be entering an inflection point in terms of both profitability and regulatory
momentum,” Will Hershey, Roundhill’s chief executive officer, said in a
statement. “WEED allows for U.S. retail and institutional investors to gain
exposure to U.S. operators, potentially in advance of positive legislation.”
Pot ETFs have grown in popularity on
Wall Street over the last two years, with the market for cannabis and
psychedelic funds pulling in about $2.3 billion in 2021, up from $686 million
the year before, according to data compiled by Bloomberg.
The uptick came as more U.S. states
adopted the legalization of marijuana for medical or recreational purposes. So
far, 37 states have legalized
marijuana for medical use, while 18 states
and Washington D.C. have legalized it for recreational use, according to the
National Organization for the Reform of Marijuana Laws.
In recent news in Germany yesterday, at least
500 pro-legalization protesters gathered in front of Berlin's Brandenburg Gate
to try to urge the government to move forward with its plans to decriminalize
the drug.
It was
Chancellor Olaf Scholz's new government who last December announced that
"We will introduce the controlled distribution of cannabis to adults for
recreational purposes in licensed stores," the government promised, before
detailing its reasons. "This will ensure quality, prevent the
proliferation of impure substances and guarantee youth protection. We will
evaluate the law's social consequences after four years."
After
more than five months and there has still been no word or timetable about when
legal stores might be opened, pro-cannabis activists are getting impatient at
what they consider unnecessary foot-dragging. After all, the Green Party, now a
part of the government coalition, has already presented a draft law to the
Bundestag in the last few years and seen it defeated.
"All
they have to do is sign it," said Martin Montana, dressed in a suit
decorated from head to foot with florescent green marijuana leaves.
"What's important is protecting young people, making sure it's not dealt
in schoolyards — all that's logical, just like with alcohol."
Montana
is a former soldier who said he used cannabis to cope with the symptoms of
post-traumatic stress disorder. "I need it to control my flashbacks, and
for the last 20 years I've managed to do that," he said. "I just want
to do that peacefully and legally."
If
you’re in New Jersey, 4/20 starts today as starting today adult-use marijuana
sales are now legal in the Garden State, opening the doors to what analysts
believe could be a $2 billion market by 2025. It’s been a long wait for New
Jersey’s proponents of recreational cannabis: Voters in the state first
approved a ballot measure legalizing recreational marijuana sales in Nov. 2020,
and Gov. Phil Murphy signed the bill into law in Feb. 2021.
Delays
in establishing a regulatory framework for the industry have left consumers
waiting more than a year for the moment when anyone over the age of 21 can walk
into one of the state’s dispensaries and walk out with legally purchased
cannabis.
So now
after a long wait, New Jersey’s dispensary owners are expecting today’s launch
to have something of “a celebratory aspect to it, for sure,” Joe Bayern, CEO of
cannabis company Curaleaf, tells CNBC Make It. “People just want to be part of
the experience and learn and come from an educational standpoint, to see what
it’s all about.”
In
another recent news article, 60 year old Michael
Barrows was one of dozens of people who lined up before dawn to join the
celebratory scene.
“It’s
pretty amazing, exciting and if I get pulled over on the way home and I’m ever
asked if I have any drugs in the car now I’m allowed to say only this,” Barrows
said, holding up the canister of marijuana flower he had just purchased. Possession
of cannabis is legal now in New Jersey, though driving under the influence is
still prohibited.
Barrows,
joined a steady stream of other novelty seekers, longtime marijuana users and
medical patients at RISE in Bloomfield, near the state's biggest city, Newark,
and not far from New York City.
Hagan
Seeley, 23, said “It feels right. It feels safe. It feels like everything you’d
want it to be rather than anything you could get anywhere else.”
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
To
hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about
investing in stocks and get investor
ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy, gaming and more. Investor Idea’s original branded content includes
podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Thursday, 21 April 2022
Wednesday, 20 April 2022
Tuesday, 19 April 2022
Monday, 18 April 2022
Thursday, 14 April 2022
Wednesday, 13 April 2022
Monday, 11 April 2022
Friday, 8 April 2022
Thursday, 7 April 2022
Investor ideas Newswire offers limited time discount to publicly traded companies
Investor ideas Newswire offers limited time discount to publicly traded companies
As inflation rises; media and social media service discounted
Vancouver, Kelowna, Delta, BC, April 7, 2022 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces it is offering a limited time special on its 2 day news and social media newswire service at https://www.investorideas.com/News-Upload/.
Read this in full at https://www.investorideas.com/news/2022/main/04072Investor-Ideas-Newswire.asp
The Investor ideas two day news and social media blast provides more social media posts than any other newswire, with your news posted a minimum of 16 times over the two days. Our 30,000 plus Twitter followers will see your news during peak trading hours at multiple time slots.
News is published on the Investorideas.com Newswire, Google news, Bing, Apple News, Quotemedia, Flipboard, Stocktwits, (if symbol allows) Blogger and other sites we own, plus RSS feeds for news apps and syndication globally.
Limited Time offer now $550 (USD) - discounted from regular $750 price.
Learn more https://www.investorideas.com/News-Upload/.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about advertising and guest posts
https://www.investorideas.com/Advertise/
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Wednesday, 6 April 2022
Tuesday, 5 April 2022
Investor Ideas #Potcasts 630, #Cannabis News and #Stocks on the Move-(CSE: $LITE.C) (CSE: $TRUL.C) (OTCQX: $TCNNF) (TSX: $LABS.TO) (TSXV: $KHRN.V)
Investor
Ideas #Potcasts 630, #Cannabis News and #Stocks on the Move-(CSE: $LITE.C)
(CSE: $TRUL.C) (OTCQX: $TCNNF) (TSX: $LABS.TO) (TSXV: $KHRN.V)
Delta, Kelowna, BC, April 5, 2022 (Investorideas.com Newswire), investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/040522-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2022/cannabis-potcasts/04051LITE-TRUL-TCNNF-LABS-KHRN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast
we look at a few private and public company announcements.
Trulieve
Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing
cannabis company in the United States, announced the launch of "4.20 for
All" Non-Fungible Tokens (NFTs) Collection. The initial offerings will be
available beginning on April 2, at 1pm EST which is exactly 420 hours prior to
April 20 (4/20), the nationally recognized cannabis holiday. Proceeds from all
Trulieve's NFT sales will benefit a charity.
The first cannabis MSO to enter the
metaverse, Trulieve's "4.20 for All" NFT Collection will be sold on
the OpenSea marketplace and can be viewed at opensea.io/collection/trulieve-420-for-all.
Each NFT features a different hand holding a cannabis product. The campaign
celebrates cannabis' diverse community and culture, which includes all types of
users and products.
This is the first in a series of
4/20 activations to be announced by Trulieve. All proceeds from the "4.20
for All" NFT Collection will be donated to the Last Prisoner Project, a
non-profit organization committed to cannabis criminal justice reform and
helping free the over 40,000 individuals still in prison for non-violent
cannabis convictions.
"Trulieve strives to provide
enhanced experiences for our customers and patients, and that now includes the
metaverse, as we introduce our '4.20 for All' NFT Collection," said Kim Rivers,
CEO of Trulieve. "This is a fun and unique way to amplify Trulieve's
steadfast belief in accessibility and to support the Last Prisoner
Project."
Highlighting some of Trulieve's most
popular products on dispensary shelves, the "4.20 for All" NFT
Collection features 10 different original pieces of digital art. There will be
42 copies of each, which results in 420 total offerings in the collection. Each
NFT will be initially offered at .042 Ethereum and every winner will receive a
premium, personalized physical gift item.
"The campaign connects to the
inclusive, diverse, and celebratory narrative that '4.20 for All'
inspires," said Valda Coryat, Trulieve's Chief Marketing Officer.
"Each illustrated hand is a hand raised supporting accessibility and
social justice. From a chef to a hiker … from a yogi to a musician … from an
astronaut to an alien and, yes, even sasquatch. We expect fans and collectors
will be excited to own these NFTs."
Customers and patients interested in
purchasing can do so without owning cryptocurrency, however they will be
required to create an account with OpenSea and transfer the necessary funds to
their digital wallet.
To learn more about Trulieve's
"4.20 for All" NFT Collection and how to purchase, please visit opensea.io/collection/trulieve-420-for-all.
MediPharm
Labs Corp.
(TSX: LABS) (OTCQX: MEDIF), a pharmaceutical company
specialized in precision-based cannabinoids, announced the expansion of its adult use
wellness product line with the launch of CBG and water-soluble products. As of
today, these new products will be available in Ontario in both retail stores
and on the OCS.ca e-commerce website. MediPharm also has purchase commitments
to distribute the products to the Company's other seven provincial distributors
in the coming months.
Bryan
Howcroft CEO of MediPharm commented, "Over the past 16 months,
MediPharm has formulated several innovative product platforms, launched them
and gained traction in the premium wellness segment of the Canadian market. The
announcement today expands the Company's portfolio to include the first
naturally derived CBG products available to Canadian adult consumers and the only
inhalable CBG option in Canada. With recent investments in sales and marketing
functions demonstrating tangible results, our team will continue to bring
differentiated wellness-focused products to market, and work to grow shelf
presence as the year progresses. We also see a meaningful opportunity to
introduce products such as those launched today into international markets,
leveraging our unique GMP Drug Establishment and Natural Health Product
manufacturing licenses, and existing global distribution partnerships."
MediPharm Labs CBG:CBD 1:2 Advanced Formula oral solution is a high-CBG
formulation, manufactured to stringent pharma-quality standards that brings
customers and patients the highest quality and purity available in the market
today. This full-spectrum formulated oil has a subtle cannabis flavour.
Northbound
CBG:CBD The White and Appalachia vape cartridge is formulated with a
terpene blend dominated by citrus zest and berry aromatic with mild herbal
notes to provide balance. Vaping enables users to experience CBG with a faster
onset that is easier to titrate.
MediPharm is proud to lead the
industry in CBG-dominant options for patients and consumers. CBG is one of the
rarer cannabinoids, and has demonstrated some potential as an antibiotic. An
interdisciplinary team of McMaster researchers, which included MediPharm's
Director of Research and Development, Dr. Tait Gale, found that CBG was not
only antibacterial, but also effective in mice against a resilient family of
bacteria known as methicillin-resistant Staphylococcus aureus
("MRSA"). Discovering that CBG has antibacterial properties was
significant given that the MRSA bacterial strain is a leading cause of
infections worldwide and has become increasingly resistant to antibiotics currently
on the market.[1]
MediPharm is also launching a water
soluble CBN:THC liquid solution, Northbound Night Cap. Northbound Night Cap
utilizes proprietary water-soluble emulsification technology developed in-house
by the MediPharm's Research and Development team. This formulation allows
patients and consumers to add CBN to their favourite food or beverage without
overpowering taste and liquid separation. Using an in-house emulsification
method mitigated the Company's need to purchase or license formulations like many
other cannabis industry beverage brands.
Khiron
Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), the global medical cannabis
leader expanding throughout Latin America and Europe, has published in the international
peer-reviewed journal Frontiers in Pain Research the results of its first clinical study on the
use of medical cannabis prescribed to Colombian patients in treating chronic
pain. This is the largest study of its
kind in Latin America, and the first published clinical evidence on the
effectiveness and safety of Khiron's THC and CBD oil-based cannabis
formulations, the two most prescribed products at Khiron's Zerenia Clinics in
Colombia. This is reassuring data for prescribing physicians and health
insurance providers on the efficacy, safety, and cost-effectiveness of the
Khiron's products to treat chronic pain. Frontiers journals rank among the most
influential in their academic fields based on total citations and ranks as the
3rd most-cited publisher among the 20 largest publishers.
The study, a joint effort by medical
researchers from Khiron Life Sciences and doctors from Zerenia Clinics in
Colombia and Europe, captures patient-reported outcome measures
("PROMS") and adverse effects in a large cohort of 2112 adult
patients diagnosed with chronic pain of diverse etiology. Between May and
September 2021, patients received adjuvant treatment with Khiron's oral
oil-based cannabis formulations at the Latin American Institute of Neurology
and Nervous System (ILANS-Zerenia) in Bogotá, Colombia.
"This study, based on Khiron's
medical products, is critical to reassure physicians and health insurance
providers of the efficacy of medicinal cannabis to treat chronic pain. The
global impact and economic burden of chronic pain in our society, mounting
medical evidence will increase access to cannabinoid-based medicines
worldwide." says Alvaro Torres, Khiron CEO and Director. "The recent
vote in the US House of Representatives promoting medical research on cannabis
clearly shows the pressing need to develop effective and safe cannabis-based
medication for suffering patients worldwide. With this and upcoming studies,
Khiron will continue to stand above in the field of medical research and to
expand the access for patients in those jurisdictions in which we are
present".
Guillermo Moreno-Sanz, the first
author of the study and Global Scientific Director of Khiron Life Sciences
adds, "We believe these findings to be generalizable across patient
populations, considering that our results are extremely well-aligned with those
reported by researchers working with similar clinical populations in nations
with long-standing medicinal cannabis access programs, such as Israel and
Canada."
This study is groundbreaking for
Khiron as most observational and experimental studies investigating the
efficacy of medical cannabis for pain management are of relatively short
duration and use a disparity of cannabinoid-based products, routes of
administration, and dosing regimens. This study is differentiated as it
describes the short-, mid- and long-term efficacy and safety of two
monovarietal formulations containing THC and CBD in different ratios (1:1 and
1:25, respectively), and investigates the contribution of patient's sex, and age.
Most participants were female (76.1%) with an average age of 58.7 years old.
One third of the participants were elderly (>65 years old).
As Khiron continues to expand its
research and business globally through Latin America and Europe, additional
studies are expected to continue to demonstrate the Company's business model,
creating a 360-solution for health care providers, insurance companies, and patients
to benefit from the prescription and positive health outcomes from medical
cannabis.
SPOTLITE360
IOT SOLUTIONS, INC. (CSE: LITE) (OTC: SPLTF) announced that it has executed a master terms
agreement dated March 30, 2022, to create a strategic relationship with American Cannabis Consulting (OTCQB:AMMJ) (ACC) an arm’s length party to the
Company. Denver, Colorado based ACC is a nationally recognized
business-to-business cannabis consulting solutions provider and licensed owner
operator with a number of significant brands and company relationships. As
recently as February 25, 2022, ACC announced a partnership with the Bubba Kush
cannabis brand.
Under the terms of the Master
Agreement, both companies will work together in joint consulting engagements to
leverage their combined strengths. SpotLite360’s recent announcement of
acquiring a majority interest in E3 Service Group, combined with SpotLite360’s
SaaS based technology and ACC's deep history of indoor cannabis cultivation
knowledge can offer best in-class design, build, total cost of ownership,
production and financial returns. SpotLite360’s technology will provide supply
chain transparency including the necessary proof of sustainability claims.
James Greenwell, President and CEO
of SpotLite360, commented, “Our companies’ have a shared vision to assist our
clients’ making data driven decisions - across a sustainable agricultural
supply chain. SpotLite360 looks forward to working together with ACC to deliver
process efficiency, support regulatory and compliance mandates, improves
product quality and provide the consumer with the proof of ESG claims that they
are now demanding. Our engineering designs and supply chain platform will drive
best in class models for optimal agricultural cultivation.”
Both companies are currently working
together on significant customer opportunities in seven (7) different states.
Most projects are new construction opportunities with several in advanced
discussions. Joint announcements are anticipated throughout the remainder of
2022.
Ellis Smith, founder and CEO of ACC,
said, “Investors and operators agree, the future of cultivation is not based on
old school mechanical systems, but technology, IOT, automation and data driven
analytics. We believe consistent and repeatable high-quality product is a
direct result of good design, good engineering, best practices, good systems,
good data and good decisions. Together our companies’ will partner with our
customers for more than a consulting agreement, or a design or an install but
for decades of joint successes.”
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about investing
in stocks and get investor ideas in
cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy,
gaming and more. Investor Idea’s original branded content includes podcasts and
columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...